Radiotherapy combined with low-dose cis-diammine dichloroplatinum (II) (cDDP) in inoperable nonmetastatic non-small cell lung cancer (NSCLC): A randomized three arm phase II study of the eortc lung cancer and radiotherapy cooperative groups

This publication has 15 references indexed in Scilit:

• Carboplatin (JM8), etoposide (VP16) and thoracic Irradiation for small cell lung cancer (S.C.L.C.): An evaluation of lung toxicity
  Radiotherapy and Oncology, 1988
• Phase II trial of combined radiotherapy and daily low-dose cisplatin for inoperable, locally advanced non-small cell lung cancer (NSCLC)
  International Journal of Radiation Oncology*Biology*Physics, 1987
• Combined treatment of radiation and cisdiamminedichloroplatinum (II): a review of experimental and clinical data
  International Journal of Radiation Oncology*Biology*Physics, 1987
• Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum(II) and irradiation
  Radiotherapy and Oncology, 1986
• Effect of cancer chemotherapeutic drugs on radiation-induced lung damage in mice
  Radiotherapy and Oncology, 1986
• The effect of treatment in fractionated schedules with the combination of x-irradiation and six cytotoxic drugs on the RIF-1 tumor and normal mouse skin
  International Journal of Radiation Oncology*Biology*Physics, 1985
• Feasibility study on daily administration of cis-diamminedichloroplatinum(II) in combination with radiotherapy
  Radiotherapy and Oncology, 1984
• Lung destruction aftercis-platinum radiosensitisation
  The British Journal of Radiology, 1983
• Enhancement of the potentiation of radiotherapy by platinum drugs in a mouse tumor
  International Journal of Radiation Oncology*Biology*Physics, 1982
• Effect of cis-dichlorodiammine platinum IIand X rays on mammalian cell survival
  International Journal of Radiation Oncology*Biology*Physics, 1981